CIK 0001671858
- Non-accelerated filer
- Smaller reporting company
ARS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SPRY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811489190
- Phone
- +1 858-771-9307
- Business address
- 11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Silverback Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-03 | Dorsey Brian Chief Operating Officer | Grant or award · Stock option (right to buy) | +145,000 | 145,000 | ||
| 2023-01-03 | Lowenthal Richard E President and CEO | Grant or award · Stock option (right to buy) | +1,100,000 | 1,100,000 | ||
| 2023-01-03 | Lowenthal Richard E President and CEO | Grant or award · Stock option (right to buy) | +350,000 | 350,000 | ||
| 2022-11-29 | Scott Kathleen D. Chief Financial Officer | Purchase | +8,250 | $6.24 | $52K | 8,250 |
| 2022-11-09 | Shawver Laura Director | Sale 10b5-1 | −43,896 | $4.58 | $201K | 210,346 |
| 2022-11-08 | Chakma Justin Chief Business Officer | Grant or award | +236,380 | 236,380 | ||
| 2022-11-08 | Chakma Justin Chief Business Officer | Grant or award · Stock option (right to buy) | +236,380 | 236,380 | ||
| 2022-11-08 | Chakma Justin Chief Business Officer | Grant or award · Stock option (right to buy) | +236,380 | 236,380 | ||
| 2022-11-08 | Chakma Justin Chief Business Officer | Grant or award · Stock option (right to buy) | +48,260 | 48,260 | ||
| 2022-11-08 | Chakma Justin Chief Business Officer | Grant or award · Stock option (right to buy) | +82,733 | 82,733 | ||
| 2022-11-08 | Karas Eric Chief Commercial Officer | Grant or award · Stock option (right to buy) | +614,588 | 614,588 | ||
| 2022-11-08 | Shah Pratik Director | Grant or award | +10,156,204 | 10,156,204 | ||
| 2022-11-08 | Shah Pratik Director | Grant or award · Employee Stock Option (right to buy) | +354,570 | 354,570 | ||
| 2022-11-08 | SCHNEIDER PHILLIP M Director | Grant or award · Stock option (right to buy) | +153,647 | 153,647 | ||
| 2022-11-08 | SCHNEIDER PHILLIP M Director | Grant or award · Stock option (right to buy) | +76,823 | 76,823 | ||
| 2022-11-08 | Tanimoto Sarina Chief Medical Officer | Grant or award | +4,326,854 | 4,326,854 | ||
| 2022-11-08 | Tanimoto Sarina Chief Medical Officer | Grant or award | +1,772,850 | 1,772,850 | ||
| 2022-11-08 | Tanimoto Sarina Chief Medical Officer | Grant or award | +1,772,850 | 1,772,850 | ||
| 2022-11-08 | Tanimoto Sarina Chief Medical Officer | Grant or award | +4,326,854 | 4,326,854 | ||
| 2022-11-08 | Tanimoto Sarina Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +82,733 | 82,733 |
Page 24 of 31 · 602 trades